Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?

× No keyword cloud information.

19 in total

Review 1. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.

Authors: Michel Azizi; Joël Ménard
Journal: Circulation Date: 2004-06-01 Impact factor: 29.690

2. Role of angiotensin receptor blockers in patients with left ventricular dysfunction: lessons from CHARM and VALIANT.

Authors: A A Voors; D J van Veldhuisen
Journal: Int J Cardiol Date: 2004-12 Impact factor: 4.164

3. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

Authors: H Urata; A Kinoshita; K S Misono; F M Bumpus; A Husain
Journal: J Biol Chem Date: 1990-12-25 Impact factor: 5.157

4. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.

Authors: S N Iyer; M C Chappell; D B Averill; D I Diz; C M Ferrario
Journal: Hypertension Date: 1998-02 Impact factor: 10.190

5. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall.

Authors: H Okunishi; M Miyazaki; N Toda
Journal: J Hypertens Date: 1984-06 Impact factor: 4.844

6. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.

Authors: J Biollaz; H R Brunner; I Gavras; B Waeber; H Gavras
Journal: J Cardiovasc Pharmacol Date: 1982 Nov-Dec Impact factor: 3.105

7. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.

Authors: R M A van de Wal; H W M Plokker; D J A Lok; F Boomsma; F A L van der Horst; D J van Veldhuisen; W H van Gilst; A A Voors
Journal: Int J Cardiol Date: 2006-01-26 Impact factor: 4.164

Review 8. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?

Authors: Ruud M A van de Wal; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Journal: Eur Heart J Date: 2005-08-16 Impact factor: 29.983

9. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors: Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal: N Engl J Med Date: 2003-11-10 Impact factor: 91.245

Review 10. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

Authors: W Linz; G Wiemer; P Gohlke; T Unger; B A Schölkens
Journal: Pharmacol Rev Date: 1995-03 Impact factor: 25.468

10 in total

1. Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients.

Authors: Martin C S Wong; Johnny Y Jiang; Xuefen Su; Haoxiang Wang; Jin Ling Tang; Sian M Griffiths
Journal: Clin Res Cardiol Date: 2010-02-21 Impact factor: 5.460

Review 2. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

Authors: Christian Werner; Janine Pöss; Michael Böhm
Journal: Drugs Date: 2010-07-09 Impact factor: 9.546

Review 3. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Authors: Christian Werner; Magnus Baumhäkel; Koon K Teo; Roland Schmieder; Johannes Mann; Thomas Unger; Salim Yusuf; Michael Böhm
Journal: Clin Res Cardiol Date: 2008-05-03 Impact factor: 5.460

4. Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials.

Authors: Lutz Frankenstein; Christian Zugck; Manfred Nelles; Dieter Schellberg; Andrew Remppis; Hugo Katus
Journal: Clin Res Cardiol Date: 2008-03-17 Impact factor: 5.460

Review 5. The case for statin therapy in chronic heart failure.

Authors: Pim van der Harst; Michael Böhm; Wiek H van Gilst; Dirk J van Veldhuisen
Journal: Clin Res Cardiol Date: 2007-12-01 Impact factor: 5.460

6. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.

Authors: D Kovacić; M Marinsek; L Gobec; M Lainscak; M Podbregar
Journal: Clin Res Cardiol Date: 2007-08-17 Impact factor: 5.460

7. Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.

Authors: Wolfgang Schillinger; Nina Hörnes; Nils Teucher; Samuel Sossalla; Daniel Sehrt; Klaus Jung; Mark Hünlich; Bernhard Unsöld; Bianca Geiling; Giuliano Ramadori; Reinhard Hilgers; Harald Schwörer; Gerd Hasenfuss
Journal: Clin Res Cardiol Date: 2009-03-20 Impact factor: 5.460

8. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors: Nicole Martin; Karthick Manoharan; Ceri Davies; R Thomas Lumbers
Journal: Cochrane Database Syst Rev Date: 2021-05-22

Review 9. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors: Nicole Martin; Karthick Manoharan; James Thomas; Ceri Davies; R Thomas Lumbers
Journal: Cochrane Database Syst Rev Date: 2018-06-28

Review 10. ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.

Authors: T S Mohamed Saleem; K Bharani; K Gauthaman
Journal: Open Access Emerg Med Date: 2010-07-01

10 in total